This site provides INTERCEPT product information for Health Care Professionals in the United States.

Cerus Webinars

Pathogen Reduction of Platelets: Patient Safety and FDA Platelet Bacterial Guidance Compliance

The FDA’s 2021 deadline to implement their bacterial risk control and mitigation guidance is rapidly approaching. This webinar provides an overview of pathogen reduction’s (PR) impact on patient safety and streamlining compliance with the FDA guidances for reducing transfusion transmission risks.

Richard J. Benjamin, MD PhD FRCPath
Chief Medical Officer
Cerus Corporation


Watch the Replay
runtime: 16 min